Related Experiment Videos

Synthesis and cleavage processing of oncornavirus proteins during interferon inhibition of virus particle release

Insights

Interferon treatment did not alter the synthesis or processing of key viral proteins in Rauscher murine leukemia virus-infected mouse cells. This antiviral protein did not impact major core or envelope glycoprotein production or their precursor cleavage.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Rauscher murine leukemia virus (RMLV) is a retrovirus that infects mouse cells.
  • Interferon is a cytokine known to have antiviral properties.
  • Understanding how interferon affects viral protein synthesis and processing is crucial for developing antiviral therapies.

Purpose of the Study:

  • To investigate the effect of interferon on the synthesis and cleavage processing of viral proteins in RMLV-infected mouse cells.
  • To determine if interferon influences the production of major core protein (p30) and envelope glycoprotein (gp69/71).

Main Methods:

  • Cells chronically infected with RMLV were pulse-labeled with [35S]methionine.
  • Newly synthesized viral proteins were immunoprecipitated and analyzed by SDS-PAGE and autoradiography.
  • Post-translational cleavage processing was assessed by pulse-chase experiments.

Main Results:

  • Interferon, at concentrations inhibiting virus release, did not affect the synthesis of p30 or gp69/71 viral proteins.
  • Interferon also did not alter the post-translational cleavage processing of precursors for p30 and gp69/71.
  • Labeling and chasing of the p15 precursor protein were also unaffected by interferon.

Conclusions:

  • Interferon does not inhibit RMLV replication by affecting the synthesis or cleavage processing of major viral structural proteins.
  • The antiviral mechanism of interferon in this model likely operates through pathways other than direct inhibition of viral protein synthesis or processing.

Related Concept Videos